Pooled analysis of prognostic impact of urokinase-type plasminogen acticvator and its inhibitor PAI-1 in 8377 breast cancer patients.

Maxime Look; Wim Putten; MJ Duffy; N Harbeck; IJ Christensen; C Thomssen; R Kates; F Spyratos; M Fernö; S Eppenberger-Castori; CGJ Sweep; K Ulm; J-P Peyrat; PM Martin; H Magdelenat; N Brüner; C Duggan; BW Lisboa; P-O Bendahl; V Quillien; A Daver; G Ricolleau; M Meijer - Gelder; P Manders; WE Fiets; MA Blankenstein; P Brot; G Daxenbichler; G Windbichler; T Cufer; S Borstnar; W Kueng; LVAM Beex; Jan Klijn; N O' Higgins; U Eppenberger; F Jäicke; M Schmitt; John Foekens

Pooled analysis of prognostic impact of urokinase-type plasminogen acticvator and its inhibitor PAI-1 in 8377 breast cancer patients.

Maxime Look, Wim Putten, MJ Duffy, N Harbeck, IJ Christensen, C Thomssen, R Kates, F Spyratos, M Fernö, S Eppenberger-Castori, CGJ Sweep, K Ulm, J-P Peyrat, PM Martin, H Magdelenat, N Brüner, C Duggan, BW Lisboa, P-O Bendahl, V QuillienA Daver, G Ricolleau, M Meijer - Gelder, P Manders, WE Fiets, MA Blankenstein, P Brot, G Daxenbichler, G Windbichler, T Cufer, S Borstnar, W Kueng, LVAM Beex, Jan Klijn, N O' Higgins, U Eppenberger, F Jäicke, M Schmitt, John Foekens

Medical Oncology

Research output: Contribution to journal › Article › Academic › peer-review

1 Downloads (Pure)

Original language	Undefined/Unknown
Pages (from-to)	116-128
Number of pages	13
Journal	Journal of the National Cancer Institute
Volume	94
Issue number	2
Publication status	Published - 2002

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

11792750.pdfFinal published version, 343 KB

http://hdl.handle.net/1765/9823

Cite this

Look, M., Putten, W., Duffy, MJ., Harbeck, N., Christensen, IJ., Thomssen, C., Kates, R., Spyratos, F., Fernö, M., Eppenberger-Castori, S., Sweep, CGJ., Ulm, K., Peyrat, J-P., Martin, PM., Magdelenat, H., Brüner, N., Duggan, C., Lisboa, BW., Bendahl, P-O., ... Foekens, J. (2002). Pooled analysis of prognostic impact of urokinase-type plasminogen acticvator and its inhibitor PAI-1 in 8377 breast cancer patients. Journal of the National Cancer Institute, 94(2), 116-128. http://hdl.handle.net/1765/9823

@article{6074d712ce464e859b97990dd4286e8b,

title = "Pooled analysis of prognostic impact of urokinase-type plasminogen acticvator and its inhibitor PAI-1 in 8377 breast cancer patients.",

author = "Maxime Look and Wim Putten and MJ Duffy and N Harbeck and IJ Christensen and C Thomssen and R Kates and F Spyratos and M Fern{\"o} and S Eppenberger-Castori and CGJ Sweep and K Ulm and J-P Peyrat and PM Martin and H Magdelenat and N Br{\"u}ner and C Duggan and BW Lisboa and P-O Bendahl and V Quillien and A Daver and G Ricolleau and {Meijer - Gelder}, M and P Manders and WE Fiets and MA Blankenstein and P Brot and G Daxenbichler and G Windbichler and T Cufer and S Borstnar and W Kueng and LVAM Beex and Jan Klijn and {O' Higgins}, N and U Eppenberger and F J{\"a}icke and M Schmitt and John Foekens",

year = "2002",

language = "Undefined/Unknown",

volume = "94",

pages = "116--128",

journal = "Journal of the National Cancer Institute",

issn = "0027-8874",

publisher = "Oxford University Press",

number = "2",

}

Look, M, Putten, W, Duffy, MJ, Harbeck, N, Christensen, IJ, Thomssen, C, Kates, R, Spyratos, F, Fernö, M, Eppenberger-Castori, S, Sweep, CGJ, Ulm, K, Peyrat, J-P, Martin, PM, Magdelenat, H, Brüner, N, Duggan, C, Lisboa, BW, Bendahl, P-O, Quillien, V, Daver, A, Ricolleau, G, Meijer - Gelder, M, Manders, P, Fiets, WE, Blankenstein, MA, Brot, P, Daxenbichler, G, Windbichler, G, Cufer, T, Borstnar, S, Kueng, W, Beex, LVAM, Klijn, J, O' Higgins, N, Eppenberger, U, Jäicke, F, Schmitt, M & Foekens, J 2002, 'Pooled analysis of prognostic impact of urokinase-type plasminogen acticvator and its inhibitor PAI-1 in 8377 breast cancer patients.', Journal of the National Cancer Institute, vol. 94, no. 2, pp. 116-128. <http://hdl.handle.net/1765/9823>

TY - JOUR

T1 - Pooled analysis of prognostic impact of urokinase-type plasminogen acticvator and its inhibitor PAI-1 in 8377 breast cancer patients.

AU - Look, Maxime

AU - Putten, Wim

AU - Duffy, MJ

AU - Harbeck, N

AU - Christensen, IJ

AU - Thomssen, C

AU - Kates, R

AU - Spyratos, F

AU - Fernö, M

AU - Eppenberger-Castori, S

AU - Sweep, CGJ

AU - Ulm, K

AU - Peyrat, J-P

AU - Martin, PM

AU - Magdelenat, H

AU - Brüner, N

AU - Duggan, C

AU - Lisboa, BW

AU - Bendahl, P-O

AU - Quillien, V

AU - Daver, A

AU - Ricolleau, G

AU - Meijer - Gelder, M

AU - Manders, P

AU - Fiets, WE

AU - Blankenstein, MA

AU - Brot, P

AU - Daxenbichler, G

AU - Windbichler, G

AU - Cufer, T

AU - Borstnar, S

AU - Kueng, W

AU - Beex, LVAM

AU - Klijn, Jan

AU - O' Higgins, N

AU - Eppenberger, U

AU - Jäicke, F

AU - Schmitt, M

AU - Foekens, John

PY - 2002

Y1 - 2002

M3 - Article

SN - 0027-8874

VL - 94

SP - 116

EP - 128

JO - Journal of the National Cancer Institute

JF - Journal of the National Cancer Institute

IS - 2

ER -